Want to learn more?
We are open to exploring industry collaborations and opportunities to co-develop SeekR therapeutic programs.
September 14, 2025
CTI Life Sciences Fund (CTI) has launched Oligon Therapeutics (OligonTx), a new biotechnology company pioneering RNA-based multi-targeting drugs as novel treatments
We are open to exploring industry collaborations and opportunities to co-develop SeekR therapeutic programs.
